Brief: Prostatype Genomics Updates On Progress With Prostatype Study
17/04/2024 12:12
April 17 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* UPDATES ON SIGNIFICANT PROGRESS IN THE US STUDY WITH
PROSTATYPE®
* EXPECTS TO SUBMIT MEDICARE APPLICATION IN Q2-Q3 2024 AND
RECEIVE
APPROVAL IN Q4 2024
Source text for Eikon: ID:nWkr7mHpCX
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue